LONZA

lonza-logo

Lonza Group AG, a Life Sciences driven chemical company, supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. The company also offers a catalogue of organic intermediates for a range of applications, such as pharmaceuticals, agrochemicals, vitamins, food and feedstuff, dyes and pigments, adhesives and fragrances. It also manufactures specialty biocides and oleochemicals; and develops and produces specific polymer inter... mediates, unsaturated polyester-resins, compounds and composites. The company operates in three divisions that include Exclusive Synthesis & Biopharmaceuticals; Organic Fine & Performance Chemicals; and Polymer Intermediates. Exclusive Synthesis & Biopharmaceuticals In the area of Exclusive Synthesis and Biopharmaceuticals, Lonza is the custom manufacturing for the global life sciences companies. In addition to Lonza's traditional chemical custom manufacturing, Lonza offers microbial custom fermentation and biotransformation services. Lonza Biologics is focused on the production of therapeutic monoclonal antibodies and recombinant proteins produced by mammalian cell cultures. Exclusive chemical synthesis: Exclusive chemical synthesis engages in the process development and manufacture of intermediates and active ingredients. It is used in Life sciences industry, pharmaceuticals and animal health products. Exclusive microbial fermentation and biotransformation: Exclusive microbial fermentation and biotransformation processes development and manufactures intermediates, active ingredients and biopharmaceuticals. Its products are used Life sciences industry, pharmaceuticals and cosmetics. The company also offers L-Carnitine (L-Carnipure), which is applicable in sports nutrition, food, pharmaceuticals and feedstuffs. Exclusive microbial biopharma fermentation: Exclusive microbial biopharma fermentation engages in the process development and manufacture of therapeutic recombinant proteins and antibody fragments. It is used in pharmaceutical and biotechnology industry. Exclusive mammalian cell fermentation: Exclusive mammalian cell fermentation engages in the process development and manufacture of therapeutic monoclonal antibodies and recombinant proteins, proprietary GS-expression system, which are used in the pharmaceutical and biotechnology industry. Organic Fine & Performance Chemicals In the area of organic fine and performance chemicals, the company develops, manufactures, and sells various organic chemical intermediates applied in pharmaceuticals, agrochemicals, vitamins, food and feed, dyes, pigments, adhesives, and fragrances, as well as polymers. The sector performance chemical is mainly engaged in the development and production of biocides and oleochemicals. These core activities are supplemented by the polymer intermediates business, including additives, unsaturated polyester resins, compounds, and composites. Organic Fine Chemicals: The company offers Niacin, niacinamide, Diketene derivatives, Hydrocyanic acid derivatives, Engineering polymer additives and Meta รขโ‚ฌโ€œ Metaldehyde. Its products are used in food and feedstuffs, pharmaceuticals, agrochemicals, colorants Vitamins, optical brighteners, agrochemicals, electronics, aerospace industry, and coating Snail. Performance Chemicals: The company offers microbiologically active substances, such as Quaternary ammonium, compounds, Halogenated hydantoins; and Hydantoin derivatives. It also offers Oleochemical derivatives. The company's products are used by the disinfectants for household, industrial and institutional applications, including water treatment and wood preservation; biocides for water treatment, pools and spas, and household disinfection; preservatives for personal care and household products; and food ingredients, humectants and emollients for personal care, processing aids and lubricants for polymer and textile industry, and industrial defoamers.

#SimilarOrganizations #People #Financial #Event #Website #More

LONZA

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
1897-01-01

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.lonza.com

Total Employee:
10001+

Status:
Active

Contact:
00041 61 316 81 11

Email Addresses:
[email protected]

Technology used in webpage:
LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Mobile Non Scaleable Content IPv6 AJAX Libraries API Google Google Cloud Cloudflare Hosting


Similar Organizations

lek-dd-logo

Lek d.d.

Lek d.d. develops, produces, and distributes generics pharmaceuticals for customers worldwide.

michrom-bioresources-logo

Michrom Bioresources

Michrom Bioresources supplies microfluidic products.

pierrel-spa-logo

Pierrel S.p.A

Pierrel S.p.A is a global service provider for the pharmaceutical, bio-pharmaceutical and life science industries.

proscon-ltd-logo

ProsCon Ltd

ProsCon Ltd is primarily serves major customers in the pharmaceutical and biotechnology markets.

leadiant-biosciences-logo

Leadiant Biosciences

Leadiant Biosciences is a pharmaceutical company dedicated to the development, registration and commercialization of effective therapies.


Current Advisors List

patrick-aebischer_image

Patrick Aebischer Member of the Board of Directors @ Lonza
Board_member
2008-03-01

angelica-kohlmann-md-phd_image

Angelica Kohlmann, MD PhD Board Member, Member NCC, ITC @ Lonza
Board_member
2018-05-04

Current Employees Featured

james-lugo_image

James Lugo
James Lugo Head, Ingredient R&D for Consumer Health & Nutrition Business Unit @ Lonza
Head, Ingredient R&D for Consumer Health & Nutrition Business Unit
2016-01-01

alice-harrison_image

Alice Harrison
Alice Harrison Global Technical Director @ Lonza
Global Technical Director
2022-01-01

maria-karatsa-dodgson_image

Maria Karatsa-Dodgson
Maria Karatsa-Dodgson Lead Scientist @ Lonza
Lead Scientist
2020-01-01

jean-aucamp_image

Jean Aucamp
Jean Aucamp Downstream processing Team Lead @ Lonza
Downstream processing Team Lead
2017-03-01

pierre-alain-ruffieux_image

Pierre-Alain Ruffieux
Pierre-Alain Ruffieux Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020) @ Lonza
Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020)
2020-06-05

uwe-gottschalk_image

Uwe Gottschalk
Uwe Gottschalk Chief Scientific Officer @ Lonza
Chief Scientific Officer
2017-07-01

dan-mirica_image

Dan Mirica
Dan Mirica Head of Global Logistics @ Lonza
Head of Global Logistics

andrew-brown_image

Andrew Brown
Andrew Brown Head of Process Development Sciences @ Lonza
Head of Process Development Sciences
2019-05-01

rob-worsena_image

Rob Worsena
Rob Worsena V.P. of Sales @ Lonza
V.P. of Sales
2016-09-01

tariq-jamal_image

Tariq Jamal
Tariq Jamal Chief Information Officer @ Lonza
Chief Information Officer
2019-01-01

Acquisitions List

Date Company Article Price
2021-11-02 Codiak Biosciences Codiak Biosciences acquired by Lonza 65 M USD
2018-10-29 Octane Biotech Octane Biotech acquired by Lonza N/A
2017-08-04 Micromacinazione Micromacinazione acquired by Lonza N/A
2017-05-30 PharmaCell PharmaCell acquired by Lonza N/A
2017-05-16 HansaBioMed HansaBioMed acquired by Lonza N/A
2016-12-12 Capsugel Capsugel acquired by Lonza 5.5 B USD
2016-08-15 InterHealth Nutraceuticals InterHealth Nutraceuticals acquired by Lonza 300 M USD
2016-06-30 Triangle Research Labs Triangle Research Labs acquired by Lonza N/A
2015-11-01 Diacon Technologies Ltd. Diacon Technologies Ltd. acquired by Lonza N/A
2015-08-03 Zelam Zelam acquired by Lonza N/A

Investments List

Date Company Article Money raised
2022-02-10 Indapta Therapeutics Lonza investment in Series A - Indapta Therapeutics 50 M USD
2021-05-03 Affinia Therapeutics Lonza investment in Series B - Affinia Therapeutics 110 M USD
2020-03-31 Affinia Therapeutics Lonza investment in Series A - Affinia Therapeutics 60 M USD
2017-05-16 Exosomics Siena Lonza investment in Funding Round - Exosomics Siena N/A
2016-12-02 ConnectedYard (pHin) Lonza investment in Series A - ConnectedYard (pHin) 7 M USD
2013-02-14 Odyssey Thera Lonza investment in Venture Round - Odyssey Thera 2.8 M USD
2009-10-22 Cilian AG Lonza investment in Corporate Round - Cilian AG N/A

Newest Events participated

natural-products-expo-west-2020_event_image Participated in Natural Products Expo West 2020 on 2020-03-03 as sponsor

mixiii-biomed-2018_event_image Participated in Mixiii Biomed 2018 on 2018-05-15 as sponsor

global-pharma-rd-informatics-congress_event_image Participated in Global Pharma R&D Informatics Congress on 2017-11-30 as sponsor

cell-gene-therapy-bioprocessing-commercialization-2017_event_image Participated in Cell & Gene Therapy Bioprocessing & Commercialization 2017 on 2017-09-25 as sponsor

bioprocess-international-european-summit-2017_event_image Participated in BioProcess International European Summit 2017 on 2017-04-25 as sponsor

cell-line-development-engineering-2017_event_image Participated in Cell Line Development & Engineering 2017 on 2017-04-24 as sponsor

Key Employee Changes

Date New article
2021-08-26 Lonza appoints Novartis executive as new Chief Financial Officer
2020-06-05 Bioavailability Enhancement โ€“ Industry Insights, Key Challenges & Advanced Development Solutions

Official Site Inspections

http://www.lonza.com

  • Host name: 51.144.88.178
  • IP address: 51.144.88.178
  • Location: Amsterdam Netherlands
  • Latitude: 52.3534
  • Longitude: 4.9087
  • Timezone: Europe/Amsterdam
  • Postal: 1091

Loading ...

More informations about "Lonza" on Search Engine